High-Sensitivity CRP and Occurrence of Cancer in Cardiovascular Disease Patients with Cardiovascular

de la Brassinne Bonardeaux, O.; Deneye, M.; Oury, C.; Moonen, M.; Lancellotti, P. High-Sensitivity CRP and Occurrence of cardiovascular disease; cancer; hs-CRP; antiplatelet; statin BMI, Body mass index; CVD, Cardiovascular disease; EF, Ejection fraction; GFR, Glomerular filtration rate; CRP, C-reactive protein; HDL, High density lipoprotein; LDL, Low density lipoprotein

Disciplines :

Cardiovascular & respiratory systems

Author, co-author :

de la Brassinne Bonardeaux, Orianne ; Université de Liège - ULiège > GIGA

Deneye, Manon ; Université de Liège - ULiège > Centres attachés à la Faculté (Médecine) > Centre d'immunologie ; Cardiology Department, Hospital Center of Bois de l'Abbaye, Seraing, Belgium

Oury, Cécile ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques

Moonen, Marie ; Université de Liège - ULiège > Département des sciences cliniques

Lancellotti, Patrizio ; Université de Liège - ULiège > Département des sciences cliniques > Cardiologie - Pathologie spéciale et réhabilitation

Language :

English

Title :

High-Sensitivity CRP and Occurrence of Cancer in Cardiovascular Disease Patients with Cardiovascular

Publication date :

12 February 2025

Journal title :

Journal of Clinical Medicine

eISSN :

2077-0383

Publisher :

MDPI

Volume :

Issue :

Pages :

1193

Peer reviewed :

Peer Reviewed verified by ORBi

Additional URL :

https://www.mdpi.com/2077-0383/14/4/1193/pdf

Funding text :

This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license

Available on ORBi :

since 19 March 2025

Statistics

Number of views

79 (6 by ULiège)

Number of downloads

31 (2 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

OpenAlex citations

Bibliography

GBD 2019 Diseases and Injuries Collaborators Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: A systematic analysis for the Global Burden of Disease Study 2019 Lancet 2020 396 1204 1222 10.1016/S0140-6736(20)30925-9 33069326
Libby P. The changing landscape of atherosclerosis Nature 2021 592 524 533 10.1038/s41586-021-03392-8 33883728
Severino P. D’Amato A. Pucci M. Infusino F. Adamo F. Birtolo L.I. Netti L. Montefusco G. Chimenti C. Lavalle C. et al. Ischemic Heart Disease Pathophysiology Paradigms Overview: From Plaque Activation to Microvascular Dysfunction Int. J. Mol. Sci. 2020 21 8118 10.3390/ijms21218118 33143256
Hansson G.K. Inflammation, Atherosclerosis, and Coronary Artery Disease N. Engl. J. Med. 2005 352 1685 1695 10.1056/NEJMra043430
Libby P. Buring J.E. Badimon L. Hansson G.K. Deanfield J. Bittencourt M.S. Tokgözoğlu L. Lewis E.F. Atherosclerosis Nat. Rev. Dis. Primers 2019 5 56 10.1038/s41572-019-0106-z 31420554
Marchio P. Guerra-Ojeda S. Vila J.M. Aldasoro M. Victor V.M. Mauricio M.D. Targeting Early Atherosclerosis: A Focus on Oxidative Stress and Inflammation Oxid. Med. Cell. Longev. 2019 2019 8563845 10.1155/2019/8563845 31354915
Moutachakkir M. Lamrani Hanchi A. Baraou A. Boukhira A. Chellak S. Immunoanalytical characteristics of C-reactive protein and high sensitivity C-reactive protein Ann. Biol. Clin. 2017 75 225 229 10.1684/abc.2017.1232 28377336
Nehring S.M. Goyal A. Patel B.C. C Reactive Protein. [Updated 2023 Jul 10] StatPearls [Internet] StatPearls Publishing Treasure Island, FL, USA 2023 Available online: https://www.ncbi.nlm.nih.gov/books/NBK441843/ (accessed on 8 February 2025)
Ridker P.M. Rifai N. Rose L. Buring J.E. Cook N.R. Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events N. Engl. J. Med. 2002 347 1557 1565 10.1056/NEJMoa021993
Mani P. Puri R. Schwartz G.G. Nissen S.E. Shao M. Kastelein J.J.P. Menon V. Lincoff A.M. Nicholls S.J. Association of Initial and Serial C-Reactive Protein Levels With Adverse Cardiovascular Events and Death After Acute Coronary Syndrome JAMA Cardiol. 2019 4 314 320 10.1001/jamacardio.2019.0179 30840024
Nozue T. Fukui K. Yamamoto S. Kunishima T. Umezawa S. Onishi Y. Tohyama S. Takeyama Y. Morino Y. Yamauchi T. et al. C-Reactive Protein and Future Cardiovascular Events in Statin-Treated Patients with Angina Pectoris: The Extended TRUTH Study J. Atheroscler. Thromb. 2013 20 717 725 10.5551/jat.18705
Ridker P.M. Bhatt D.L. Pradhan A.D. Glynn R.J. MacFadyen J.G. E Nissen S. Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: A collaborative analysis of three randomised trials Lancet 2023 401 1293 1301 10.1016/S0140-6736(23)00215-5
Calabró P. Willerson J.T. Yeh E.T. Inflammatory Cytokines Stimulated C-Reactive Protein Production by Human Coronary Artery Smooth Muscle Cells Circulation 2003 108 1930 1932 10.1161/01.CIR.0000096055.62724.C5 14530191
Zhu Y. Xian X. Wang Z. Bi Y. Chen Q. Han X. Tang D. Chen R. Research Progress on the Relationship between Atherosclerosis and Inflammation Biomolecules 2018 8 80 10.3390/biom8030080 30142970
Pearson T.A. Mensah G.A. Alexander R.W. Anderson J.L. Cannon R.O. III Criqui M. Fadl Y.Y. Fortmann S.P. Hong Y. Myers G.L. et al. Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: A Statement for Healthcare Professionals From the Centers for Disease Control and Prevention and the American Heart Association Circulation 2003 107 499 511 10.1161/01.CIR.0000052939.59093.45 12551878
Greten F.R. Grivennikov S.I. Inflammation and Cancer: Triggers, Mechanisms, and Consequences Immunity 2019 51 27 41 10.1016/j.immuni.2019.06.025
Quispe R. Michos E.D. Martin S.S. Puri R. Toth P.P. Al Suwaidi J. Banach M. Virani S.S. Blumenthal R.S. Jones S.R. et al. High-Sensitivity C-Reactive Protein Discordance With Atherogenic Lipid Measures and Incidence of Atherosclerotic Cardiovascular Disease in Primary Prevention: The ARIC Study J. Am. Hear. Assoc. 2020 9 e013600 10.1161/JAHA.119.013600 32013698
Ridker P.M. Lei L. Louie M.J. Haddad T. Nicholls S.J. Lincoff A.M. Libby P. Nissen S.E. on behalf of the CLEAR Outcomes Investigators Inflammation and Cholesterol as Predictors of Cardiovascular Events Among 13 970 Contemporary High-Risk Patients With Statin Intolerance Circulation 2024 149 28 35 10.1161/CIRCULATIONAHA.123.066213 37929602
Balkwill F. Mantovani A. Inflammation and cancer: Back to Virchow? Lancet 2001 357 539 545 10.1016/S0140-6736(00)04046-0 11229684
Singh N. Baby D. Rajguru J.P. Patil P.B. Thakkannavar S.S. Pujari V.B. Inflammation and cancer Ann. Afr. Med. 2019 18 121 126 10.4103/aam.aam_56_18 31417011
Prousi G.S. Joshi A.M. Atti V. Addison D. Brown S.-A. Guha A. Patel B. Vascular Inflammation, Cancer, and Cardiovascular Diseases Curr. Oncol. Rep. 2023 25 955 963 10.1007/s11912-023-01426-0 37261651
Lancellotti P. Marechal P. Donis N. Oury C. Inflammation, cardiovascular disease, and cancer: A common link with far-reaching implications Eur. Hear. J. 2019 40 3910 3912 10.1093/eurheartj/ehz645
Klooster C.C.V. Ridker P.M. Hjortnaes J. van der Graaf Y. Asselbergs F.W. Westerink J. Aerts J.G.J.V. Visseren F.L.J. The relation between systemic inflammation and incident cancer in patients with stable cardiovascular disease: A cohort study Eur. Hear. J. 2019 40 3901 3909 10.1093/eurheartj/ehz587 31504409
Zhu M. Ma Z. Zhang X. Hang D. Yin R. Feng J. Xu L. Shen H. C-reactive protein and cancer risk: A pan-cancer study of prospective cohort and Mendelian randomization analysis BMC Med. 2022 20 301 10.1186/s12916-022-02506-x 36117174
Allin K.H. Nordestgaard B.G. Zacho J. Tybjærg-Hansen A. Bojesen S.E. C-Reactive Protein and the Risk of Cancer: A Mendelian Randomization Study JNCI J. Natl. Cancer Inst. 2010 102 202 206 10.1093/jnci/djp459 20056955
Si S. Li J. Tewara M.A. Xue F. Genetically Determined Chronic Low-Grade Inflammation and Hundreds of Health Outcomes in the UK Biobank and the FinnGen Population: A Phenome-Wide Mendelian Randomization Study Front. Immunol. 2021 12 720876 10.3389/fimmu.2021.720876
Markozannes G. Koutsioumpa C. Cividini S. Monori G. Tsilidis K.K. Kretsavos N. Theodoratou E. Gill D. Ioannidis J.P. Tzoulaki I. Global assessment of C-reactive protein and health-related outcomes: An umbrella review of evidence from observational studies and Mendelian randomization studies Eur. J. Epidemiol. 2021 36 11 36 10.1007/s10654-020-00681-w 32978716
Muller D.C. Larose T.L. Hodge A. Guida F. Langhammer A. Grankvist K. Meyer K. Cai Q. A Arslan A. Zeleniuch-Jacquotte A. et al. Circulating high sensitivity C reactive protein concentrations and risk of lung cancer: Nested case-control study within Lung Cancer Cohort Consortium BMJ 2019 364 k4981 10.1136/bmj.k4981 30606716
Guirguis-Blake J.M. Evans C.V. Perdue L.A. Bean S.I. Senger C.A. Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: An Evidence Update for the U.S. Preventive Services Task Force [Internet] Agency for Healthcare Research and Quality (US) Rockville, MD, USA 2022
Elwood P. Protty M. Morgan G. Pickering J. Delon C. Watkins J. Aspirin and cancer: Biological mechanisms and clinical outcomes Open Biol. 2022 12 220124 10.1098/rsob.220124 36099932
Soehnlein O. Libby P. Targeting inflammation in atherosclerosis—From experimental insights to the clinic Nat. Rev. Drug Discov. 2021 20 589 610 10.1038/s41573-021-00198-1 33976384
Ridker P.M. Everett B.M. Thuren T. MacFadyen J.G. Chang W.H. Ballantyne C. Fonseca F. Nicolau J. Koenig W. Anker S.D. et al. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease N. Engl. J. Med. 2017 377 1119 1131 10.1056/NEJMoa1707914 28845751
Zhao X. Xu Z. Li H. NSAIDs Use and Reduced Metastasis in Cancer Patients: Results from a meta-analysis Sci. Rep. 2017 7 1875 10.1038/s41598-017-01644-0 28500305
Chen Z. Wu P. Wang J. Chen P. Fang Z. Luo F. The association of statin therapy and cancer: A meta-analysis Lipids Health Dis. 2023 22 192 10.1186/s12944-023-01955-4 37950285
Kandelouei T. Abbasifard M. Imani D. Aslani S. Razi B. Fasihi M. Shafiekhani S. Mohammadi K. Jamialahmadi T. Reiner Ž. et al. Effect of Statins on Serum level of hs-CRP and CRP in Patients with Cardiovascular Diseases: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Mediat. Inflamm. 2022 2022 8732360 10.1155/2022/8732360 35125965
Santas E. Villar S. Palau P. Llàcer P. de la Espriella R. Miñana G. Lorenzo M. Núñez-Marín G. Górriz J.L. Carratalá A. et al. High-sensitivity C-reactive protein and risk of clinical outcomes in patients with acute heart failure Sci. Rep. 2024 14 21672 10.1038/s41598-024-72137-0 39289385